Steroid therapy still plays a crucial role and could serve as a bridge to the next promising treatments in patients with IgG4 ‐related sclerosing cholangitis: Results of a Japanese Nationwide Study

ConclusionSteroid therapy should be continued for no less than three years to reduce the risk of relapse, with use of preemptive measures taken around five years. The biliary drainage might not be mandatory. Steroid as 1st line therapy could serve as a bridge to further promising treatments.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - April 23, 2022 Category: Gastroenterology Authors: Kensuke Kubota, Terumi Kamisawa, Takahiro Nakazawa, Atsushi Tanaka, Itaru Naitoh, Hajime Takikawa, Michiaki Unno, Shigeyuki Kawa, Atsushi Masamune, Seiji Nakamura, Kazuichi Okazaki, Collaborators Tags: ORIGINAL ARTICLE Source Type: research